718
statement on methodology and indications endorsed by the Japanese Society of
Echocardiography. J Am Soc Echocardiogr
24
(3), 277-313 (2011).
26. Savu O.; Jurcut R.; Giusca S.; van Mieghem T.; Gussi I.; Popescu BA.; Ginghina C.;
Rademakers F.; Deprest J.; Voigt JU. Morphological and functional adaptation of the
maternal heart during pregnancy. Circ Cardiovasc Imaging
5
(3), 289-297 (2012).
27. Cuvillier O.; Pirianov G.; Kleuser B.; Vanek PG.; Coso OA.; Gutkind S.; Spiegel S. Suppression
of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature
381
(6585), 800-803 (1996).
28. Jin ZQ.; Zhang J.; Huang Y.; Hoover HE.; Vessey DA.; Karliner JS. A sphingosine kinase 1
mutation sensitizes the myocardium to ischemia/reperfusion injury. Cardiovasc Res
76
(1),
41-50 (2007).
29. Jin ZQ.; Goetzl EJ.; Karliner JS. Sphingosine kinase activation mediates ischemic
preconditioning in murine heart. Circulation
110
(14), 1980-1989 (2004).
30. Theilmeier G.; Schmidt C.; Herrmann J.; Keul P.; Schafers M.; Herrgott I.; Mersmann J.;
Larmann J.; Hermann S.; Stypmann J.; Schober O.; Hildebrand R.; Schulz R.; Heusch G.;
Haude M.; von Wnuck Lipinski K.; Herzog C.; Schmitz M.; Erbel R.; Chun J.; Levkau B. High-
density lipoproteins and their constituent.; sphingosine-1-phosphate.; directly protect the
heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Circulation
114
(13), 1403-1409 (2006).
31. Piot C.; Croisille P.; Staat P.; Thibault H.; Rioufol G.; Mewton N.; Elbelghiti R.; Cung TT.;
Bonnefoy E.; Angoulvant D.; Macia C.; Raczka F.; Sportouch C.; Gahide G.; Finet G.; Andre-
Fouet X.; Revel D.; Kirkorian G.; Monassier JP.; Derumeaux G.; Ovize M. Effect of
cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med
359
(5),
473-481 (2008).
32. Ovize M.; Baxter GF.; Di Lisa F.; Ferdinandy P.; Garcia-Dorado D.; Hausenloy DJ.; Heusch G.;
Vinten-Johansen J.; Yellon DM.; Schulz R. Postconditioning and protection from
reperfusion injury, where do we stand? Position paper from the Working Group of
Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res
87
(3),
406-423 (2010).
33. Kwong RY.; Chan AK.; Brown KA.; Chan CW.; Reynolds HG.; Tsang S.; Davis RB. Impact of
unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-
free survival in patients presenting with signs or symptoms of coronary artery disease.
Circulation
113
(23), 2733-2743 (2006).
34. Cheong BY.; Muthupillai R.; Wilson JM.; Sung A.; Huber S.; Amin S.; Elayda MA.; Lee VV.;
Flamm SD. Prognostic significance of delayed-enhancement magnetic resonance imaging,
survival of 857 patients with and without left ventricular dysfunction. Circulation
120
(21),
2069-2076 (2009).
35. Yan AT.; Shayne AJ.; Brown KA.; Gupta SN.; Chan CW.; Luu TM.; Di Carli MF.; Reynolds HG.;
Stevenson WG.; Kwong RY. Characterization of the peri-infarct zone by contrast-enhanced
cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction
mortality. Circulation
114
(1), 32-39 (2006).
36. Kelle S.; Roes SD.; Klein C.; Kokocinski T.; de Roos A.; Fleck E.; Bax JJ.; Nagel E. Prognostic
value of myocardial infarct size and contractile reserve using magnetic resonance imaging.
J Am Coll Cardiol
54
(19), 1770-1777 (2009).
37. Wu E.; Ortiz JT.; Tejedor P.; Lee DC.; Bucciarelli-Ducci C.; Kansal P.; Carr JC.; Holly TA.;
Lloyd-Jones D.; Klocke FJ.; Bonow RO. Infarct size by contrast enhanced cardiac magnetic
resonance is a stronger predictor of outcomes than left ventricular ejection fraction or
end-systolic volume index, prospective cohort study. Heart
94
(6), 730-736 (2008).
38. Masci PG.; Ganame J.; Strata E.; Desmet W.; Aquaro GD.; Dymarkowski S.; Valenti V.;
Janssens S.; Lombardi M.; Van de Werf F.; L'Abbate A.; Bogaert J. Myocardial salvage by
CMR correlates with LV remodeling and early ST-segment resolution in acute myocardial
infarction. JACC Cardiovasc Imaging
3
(1), 45-51 (2010).
39. Solomon SD.; Anavekar N.; Skali H.; McMurray JJ.; Swedberg K.; Yusuf S.; Granger CB.;
Michelson EL.; Wang D.; Pocock S.; Pfeffer MA. Influence of ejection fraction on
cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation
112
(24), 3738-3744 (2005).
40. Williams MJ.; Odabashian J.; Lauer MS.; Thomas JD.; Marwick TH. Prognostic value of
dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll
Cardiol.
27
(1), 132-139 (1996).
